GSK3β-Ikaros-ANXA4 signaling inhibits high-glucose-induced fibroblast migration

Youpei Wang,Xiang Zheng,Qing Wang,Meiqin Zheng,Lingxia Pang

DOI: https://doi.org/10.1016/j.bbrc.2020.07.142

IF: 3.1

2020-10-01

Biochemical and Biophysical Research Communications

Abstract:<p>Previous studies showed that the activation of Wnt signaling reduced high glucose (HG)-mediated fibroblast damage, but the molecular basis for this phenomenon remains elusive. This study aimed to analyze the level of phosphorylation of GSK3β Ser⁹ (pGSK3β Ser⁹) during HG damage. Moreover, the phosphomimic form of pGSK3β Ser9 was expressed to analyze its effect on cell migration via the phosphorylation of Ikaros. The results revealed that HG treatment significantly reduced the pGSK3β Ser⁹ level. The overexpression of GSK3β Ser⁹D and GSK3β Ser⁹A accelerated and inhibited fibroblast cell migration, respectively. <em>P110α</em> knockdown or treatment with SP600125, an inhibitor of JNK, also reduced the pGSK3β Ser⁹ level under HG condition. Treatment with SP600125 inhibited the migration of fibroblasts, but not in GSK3β Ser⁹D–expressing cells. Further, yeast two-hybrid screening and biochemical analysis identified that GSK3β interacted and phosphorylated Ikaros at Ser³⁹¹. Besides, GSK3β Ser⁹D, but not GSK3β Ser⁹A, activated Ikaros Ser³⁹¹ phosphorylation. Expressing Ikaros or β-catenin significantly promoted cell migration, suggesting that GSK3β modulated cell migration partially via the activation of Ikaros besides β-catenin signaling under HG condition. The expression of the phosphomimic form of Ikaros Ser³⁹¹D resulted in a significant increase in the extent of cell migration compared with Ikaros under HG condition. Moreover, the Ikaros Ser³⁹¹D DNA-binding affinity toward the <em>ANXA4</em> promoter increased, and <em>ANXA4</em> suppression promoted cell migration. In conclusion, the results of this study provided a new regulatory mechanism by which GSK3β negatively regulated human skin fibroblast cell migration.</p>

biochemistry & molecular biology,biophysics

What problem does this paper attempt to address?

The paper primarily explores a specific technique used during Right Hepatectomy (RH)—that is, the separation and ligation of extrahepatic vessels prior to the parenchymal transection without routinely employing Portal Triad Clamping (PTC). The study aims to assess the feasibility and effectiveness of this technique in patients without cirrhosis.

**Research Background and Purpose**:
- Right hepatectomy is one of the most common major liver resection surgeries, which can be completed in non-cirrhotic patients without using Portal Triad Clamping.
- Portal Triad Clamping may cause ischemia/reperfusion injury to the remaining liver, affecting liver function and increasing the risk of postoperative complications.
- The study aims to analyze the feasibility and outcomes of right hepatectomy using the technique of extrahepatic vascular separation and ligation followed by parenchymal transection in non-cirrhotic patients.

**Methods**:
- An analysis was conducted on 181 consecutive cases of right hepatectomy performed at a single institution between 2000 and 2010.
- None of the patients underwent routine Portal Triad Clamping.
- Key indicators focused on included the necessity for remedial Portal Triad Clamping, ischemia time, blood loss, and postoperative outcomes.

**Results**:
- The separation and ligation of extrahepatic vessels were feasible in all patients, but 26.5% required remedial Portal Triad Clamping during the parenchymal transection.
- The median ischemia time for patients requiring remedial Portal Triad Clamping was 20 minutes.
- The median blood loss was 500 milliliters.
- The overall complication rate was 42%, with a severe complication rate of 12.1%, and a mortality rate of 1.6%.
- The perioperative transfusion rate (16.6%) was the only factor associated with complications.

**Conclusion**:
- In non-cirrhotic patients, right hepatectomy using the technique of extrahepatic vascular separation and ligation followed by parenchymal transection can safely avoid Portal Triad Clamping in most patients.
- This technique helps to reduce ischemia/reperfusion injury, enhancing the safety and efficacy of the surgery.